0658 GMT - Raffles Medical Group's China hospitals are likely to break even in 2026, Maybank Securities analyst Eric Ong writes in a note. The Singapore-listed private healthcare provider's hospital portfolio in China is showing decent progress, with a 10% on-year increase in turnover in 2024, he says. The group's China operations are on a promising growth trajectory, he adds. Management now expects its China operations to achieve breakeven in earnings before interest, taxes, depreciation, and amortization in 2026, as it continues to increase bed utilization there, Ong says. Maybank upgrades the stock's rating to buy from hold, raising the target price to S$1.03 from S$1.00. Shares are at S$0.91.(amanda.lee@wsj.com)
(END) Dow Jones Newswires
February 25, 2025 01:58 ET (06:58 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。